Zahra Sadat Hashemi
Overview
Explore the profile of Zahra Sadat Hashemi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
286
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shakerian N, Tafazoli A, Razavinia A, Sadrzadeh Aghajani Z, Bana N, Mard-Soltani M, et al.
Pancreas
. 2024 Dec;
54(3):e255-e267.
PMID: 39661050
Unusual symptoms, rapid progression, lack of reliable early diagnostic biomarkers, and lack of efficient treatment choices are the ongoing challenges of pancreatic cancer. Numerous research studies have demonstrated the correlation...
2.
Hashemi Z, Ghavami M, Mohammadi F, Shokrollahi Barough M, Shokati F, Asghari S, et al.
Iran J Basic Med Sci
. 2024 Nov;
27(12):1604-1615.
PMID: 39539445
Objectives: Natural killer (NK) cells are the most professional innate immune cells that initiate extracellular apoptosis via cytotoxic granules in malignant cells. Antitumoral properties of NK-derived exosomes (Exos) are attributed...
3.
Hashemi Z, Khalili S, Shokrollahi Barough M, Sarrami Forooshani R, Sanati H, Sarafrazi Esfandabadi F, et al.
Int J Biol Macromol
. 2024 Jul;
277(Pt 3):134066.
PMID: 39059530
Transduced MSCs that express engineered ACE2 could be highly beneficial to combat COVID-19. Engineered ACE2 can act as decoy targets for the virus, preventing its entry into healthy lung cells....
4.
Shakerian N, Darzi-Eslam E, Afsharnoori F, Bana N, Noorabad Ghahroodi F, Tarin M, et al.
Med Oncol
. 2024 Jul;
41(8):203.
PMID: 39031221
Exosomes play a key role in colorectal cancer (CRC) related processes. This review explores the various functions of exosomes in CRC and their potential as diagnostic markers, therapeutic targets, and...
5.
Razavinia A, Razavinia A, Jamshidi Khalife Lou R, Ghavami M, Shahri F, Tafazoli A, et al.
Heliyon
. 2024 Jul;
10(12):e32875.
PMID: 38948044
Background: Renal Cell Carcinoma (RCC) stands as a formidable challenge within the field of oncology, despite considerable research endeavors. The advanced stages of this malignancy present formidable barriers to effective...
6.
Ramezani A, Tafazoli A, Salimi F, Ghavami M, Arjmandi H, Khalesi B, et al.
Arch Biochem Biophys
. 2024 Apr;
756:109994.
PMID: 38626818
Interactions between the plasma cells and the BM microenvironment of Multiple myeloma (MM) take place through factors such as exosomes. Many studies have confirmed the role of exosomes in these...
7.
Hashemi Z, Moghadam M, Khalili S, Hashemi S, Sepehr K, Sadroddiny E
Curr Stem Cell Res Ther
. 2024 Jan;
19(11):1525-1534.
PMID: 38265389
Background: MSCs are a part of the tumor microenvironment, which secrete cytokines and chemokines. They can affect metastasis and the growth of tumors. metastamiRs are newly recognized regulatory elements of...
8.
Karami Fath M, Khalili S, Boojar M, Hashemi Z, Zarei M
Curr Comput Aided Drug Des
. 2023 Nov;
20(7):1100-1112.
PMID: 37957909
Background: (HP) infection could lead to various gastrointestinal diseases. Urease is the most important virulence factor of HP. It protects the bacterium against gastric acid. Objective: Therefore, we aimed to...
9.
Hatami Z, Hashemi Z, Eftekhary M, Amiri A, Karpisheh V, Nasrollahi K, et al.
Cancer Cell Int
. 2023 Aug;
23(1):157.
PMID: 37543612
Chimeric antigen receptor natural killer cells (CAR-NK) promote off-the-shelf cellular therapy for solid tumors and malignancy.However,, the development of CAR-NK is due to their immune surveillance uncertainty and cytotoxicity challenge...
10.
Ahmadvand M, Shokrollahi Barough M, Hashemi Z, Sanati H, Abbasvandi F, Yunesian M, et al.
Pilot Feasibility Stud
. 2023 Aug;
9(1):137.
PMID: 37542307
Background: NK cells are the most active innate immune cells in antiviral immunity, which are impaired by SARS-COV2 infection. Infusion of allogeneic NK cells might be a complementary treatment to...